Who Should Be Able to Prescribe the New Diabetes Medication in Tunisia?

The accessibility of a new diabetes medication in Tunisia is at the center of a debate, with Dr. Habib Jerbi, president of the Tunisian Association of General and Family Medicine, voicing significant concerns. Jerbi argues that limiting the prescription of this crucial new treatment to specialists, as proposed by the National Medicines Agency, could create unnecessary barriers for patients seeking timely care. He emphasizes that general practitioners and family doctors are fundamental pillars of the healthcare system, playing vital roles in diagnosing, screening, and managing chronic conditions like diabetes.

“

l’exclusion des médecins de première ligne de la prescription du nouveau médicament contre le diabète pourrait compliquer l’accès des patients au traitement.

Speaking on Diwan FM, Jerbi highlighted that primary care physicians are often the first point of contact for patients and are well-equipped to handle the long-term care of individuals with chronic illnesses. Restricting their ability to prescribe new treatments, he believes, not only complicates patient access but also overlooks the essential role they play in the healthcare continuum. Jerbi pointed out that the current decision regarding prescription limitations may not be legally binding and called for a clear definition of the regulatory framework governing this measure.

“

les médecins généralistes et les médecins de famille constituent un pilier essentiel du système de santé, notamment dans le diagnostic, le dépistage et le suivi des patients atteints de maladies chroniques comme le diabète.

Jerbi advocates for a revised approach that would integrate primary care physicians into the prescribing process. He stressed that this integration should be governed by stringent conditions and clearly defined protocols, potentially including a dedicated registry supervised by the Ministry of Health. Such a system, he contends, would strike a balance between ensuring the safe and appropriate use of the medication and improving patient access to innovative treatments. This perspective underscores the importance of a patient-centered approach that leverages the expertise of all levels of medical practitioners.

“

la décision relative à la limitation de la prescription de ce médicament, telle qu’annoncée par l’Agence nationale du médicament, ne serait pas juridiquement contraignante.

From a Tunisian perspective, ensuring equitable access to essential medicines is paramount, especially for chronic diseases that affect a significant portion of the population. While patient safety is a critical consideration, overly restrictive measures can inadvertently create a two-tiered system where those with easier access to specialists receive timely treatment, while others face delays and potential complications. The call for clarity and a more inclusive prescribing framework reflects a desire to optimize the healthcare system's efficiency and effectiveness, ensuring that all patients, regardless of their location or initial point of care, can benefit from medical advancements.

“

une telle approche permettrait de concilier sécurisation de la prescription et amélioration de l’accès des patients aux nouveaux traitements.